Report Categories
View AllRecent Articles
View All
NDSN Q1 2026 Earnings EPS Just Misses Estimates as Costs Weigh on Margins
Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline
SU Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency Amid Market Challenges
GTEC Q4 2025 Earnings Significant EPS Miss Despite Slight Stock Uptick
MTB Q1 2026 Earnings EPS Surpasses Estimates Shares Edge Higher